Business Description
Tianda Pharmaceuticals Ltd
ISIN : KYG887471038
Compare
Compare
Traded in other countries / regions
00455.Hong Kong IPO Date
1992-03-30Description
Tianda Pharmaceuticals Ltd is engaged in R&D, manufacturing, and sales of pharmaceutical, biotechnology, and healthcare products, and investment in the development of the Chinese medicine industry. The group also engages in R&D of Chinese medicine and manufacture and sales of Chinese medicine products, and the provision of Chinese medical services. Its operating segments include the Chinese medicine business; Medical and healthcare services; and Pharmaceuticals and medical technologies business. The company derives the majority of its revenue from the Pharmaceuticals and medical technologies business.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.43 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | -5.48 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.68 | |||||
Beneish M-Score | -2.44 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.6 | |||||
3-Year EBITDA Growth Rate | -25.6 | |||||
3-Year FCF Growth Rate | 1.8 | |||||
3-Year Book Growth Rate | -6.5 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 95.42 | |||||
9-Day RSI | 82.25 | |||||
14-Day RSI | 71.82 | |||||
6-1 Month Momentum % | 11.16 | |||||
12-1 Month Momentum % | 19.14 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.1 | |||||
Quick Ratio | 0.89 | |||||
Cash Ratio | 0.52 | |||||
Days Inventory | 87.32 | |||||
Days Sales Outstanding | 62.01 | |||||
Days Payable | 138.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.02 | |||||
3-Year Dividend Growth Rate | 44.2 | |||||
Forward Dividend Yield % | 1.02 | |||||
5-Year Yield-on-Cost % | 0.51 | |||||
Shareholder Yield % | 1 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 48.02 | |||||
Operating Margin % | -4.59 | |||||
Net Margin % | -4.54 | |||||
FCF Margin % | -21.81 | |||||
ROE % | -4.05 | |||||
ROA % | -2.56 | |||||
ROIC % | -3.19 | |||||
ROC (Joel Greenblatt) % | -5.03 | |||||
ROCE % | -3.28 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.09 | |||||
PB Ratio | 0.96 | |||||
Price-to-Tangible-Book | 1.23 | |||||
EV-to-EBIT | -26.14 | |||||
EV-to-EBITDA | -26.14 | |||||
EV-to-Revenue | 1.02 | |||||
EV-to-FCF | -4.4 | |||||
Price-to-Median-PS-Value | 0.79 | |||||
Price-to-Net-Current-Asset-Value | 27 | |||||
Earnings Yield (Greenblatt) % | -3.83 | |||||
FCF Yield % | -19.99 | |||||
Forward Rate of Return (Yacktman) % | 16.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tianda Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 532.089 | ||
EPS (TTM) (HK$) | -0.011 | ||
Beta | 0.13 | ||
Volatility % | 29.78 | ||
14-Day RSI | 71.82 | ||
14-Day ATR (HK$) | 0.004923 | ||
20-Day SMA (HK$) | 0.24965 | ||
12-1 Month Momentum % | 19.14 | ||
52-Week Range (HK$) | 0.18 - 0.28 | ||
Shares Outstanding (Mil) | 2,150.04 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Tianda Pharmaceuticals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Tianda Pharmaceuticals Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Tianda Pharmaceuticals Ltd Frequently Asked Questions
What is Tianda Pharmaceuticals Ltd(HKSE:00455)'s stock price today?
The current price of HKSE:00455 is HK$0.27. The 52 week high of HKSE:00455 is HK$0.28 and 52 week low is HK$0.18.
When is next earnings date of Tianda Pharmaceuticals Ltd(HKSE:00455)?
The next earnings date of Tianda Pharmaceuticals Ltd(HKSE:00455) is .
Does Tianda Pharmaceuticals Ltd(HKSE:00455) pay dividends? If so, how much?
The Dividend Yield %  of Tianda Pharmaceuticals Ltd(HKSE:00455) is 1.02% (As of Today), Highest Dividend Payout Ratio of Tianda Pharmaceuticals Ltd(HKSE:00455) was 3. The lowest was 0.31. And the median was 1. The  Forward Dividend Yield % of Tianda Pharmaceuticals Ltd(HKSE:00455) is 1.02%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |